Mantle cell lymphoma trials in United States

In United States 82 Also abroad 150

82 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 1Taking people
Pacritinib in Combination With a BTK Inhibitor for the Treatment of Patients With Relapsed or Refractory Mantle Cell Lymphoma
Where
Duarte
Age
18 years and over
People
10
Run by
City of Hope Medical Center
See details and how to joinNCT06675123
Phase 1Taking people
CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma
Where
Boston
Age
18 years and over
People
24
Run by
Marcela V. Maus, M.D.,Ph.D.
See details and how to joinNCT06026319
Phase 1/2Taking people
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Where
Augusta, Baton Rouge, Bethesda, Birmingham, Boston, Buffalo, Chattanooga, Detroit, Fort Collins, Houston, Iowa City, Jacksonville, La Jolla, Las Vegas, Louisville, Miami, Nashville, Newnan, New York, Palo Alto, Phoenix, Richmond, Rochester, Santa Monica, Scottsdale, Seattle, Tampa, Tucson, Zion
Age
18 years and over
People
689 worldwide
Run by
BeOne Medicines
See details and how to joinNCT05006716 · EU 2022-502157-33-00
Phase 2Taking people
Intrathecal Cytarabine and Hydrocortisone for the Early Treatment of ICANS in Patients Undergoing CAR T Therapy for Non Hodgkin Lymphoma
Where
Nashville
Age
18 years and over
People
59
Run by
Vanderbilt-Ingram Cancer Center
See details and how to joinNCT07763210
Phase 2Taking people
Glofitamab With Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma
Where
Davis, Los Angeles, San Diego, San Francisco
Age
18 years and over
People
30
Run by
University of California, San Francisco
See details and how to joinNCT06252675
Phase 1/2Taking people
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
Where
Boston, Charlotte, Hackensack, Houston, La Jolla, New York, Rochester, Seattle, Winston-Salem
Age
18 years and over
People
174 worldwide
Run by
AstraZeneca
See details and how to joinNCT06542250
Phase 2Taking people
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Where
Jacksonville
Age
18 years and over
People
27
Run by
Mayo Clinic
See details and how to joinNCT07285044
Phase 2Taking people
Phase 2 Open Label Randomized Study of Pirtobrutinib and Brexucabtagene Autoleucel in R/R MCL
Where
Miami, Stanford, Tampa
Age
18 years and over
People
60
Run by
H. Lee Moffitt Cancer Center and Research Institute
See details and how to joinNCT06553872
No phaseTaking people
Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment
Where
Portland
Age
18 years and over
People
45
Run by
OHSU Knight Cancer Institute
See details and how to joinNCT06784167
Phase 1/2Taking people
Zanubrutinib and Tafasitamab in Mantle Cell Lymphoma
Where
Miami
Age
18 years and over
People
27
Run by
Alvaro Alencar, MD
See details and how to joinNCT06029309
Phase 1Enrolling by invitation
CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas
Where
Baltimore
Age
18 years and over
People
15
Run by
University of Maryland, Baltimore
See details and how to joinNCT07168486
Phase 1Taking people
Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
Where
Cleveland
Age
18 years and over
People
15
Run by
Paolo Caimi, MD
See details and how to joinNCT07225439
Phase 2Taking people
Nemtabrutinib With CAR T Therapy in Relapsed/Refractory Mantle Cell Lymphoma
Where
Nashville
Age
18 years and over
People
25
Run by
Vanderbilt-Ingram Cancer Center
See details and how to joinNCT07673367
Phase 1Taking people
AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas
Where
Palo Alto
Age
18 years and over
People
148
Run by
Stanford University
See details and how to joinNCT06340737
Phase 1Taking people
Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies
Where
Los Angeles
Age
18 years to 85 years
People
20
Run by
Joshua Sasine, MD, PhD
See details and how to joinNCT05887167
Phase 1Taking people
LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies
Where
Milwaukee
Age
18 years to 81 years
People
12
Run by
Medical College of Wisconsin
See details and how to joinNCT05990465
Phase 2Not yet taking people in United States
Glofitamab in B-NHL Using Mid-Therapy Intratumoral Transcriptomics
Where
New York
Age
18 years and over
People
16
Run by
Joshua Brody
See details and how to joinNCT07748364
Phase 1Taking people
This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
Where
Buffalo, Duarte, Nashville, New York, Seattle, St Louis
Age
18 years and over
People
42
Run by
LTZ Therapeutics, Inc.
See details and how to joinNCT07121946
No phaseNot yet taking people in United States
Atrial Fibrillation Among Patients With Hematologic Malignancies on Tyrosine Kinase Inhibitor Therapy
Where
Duarte, San Diego, Stanford
Age
18 years and over
People
500
Run by
Tina Baykaner
See details and how to joinNCT07711327
Phase 2Taking people
DALY II USA/ MB-CART2019.1 for DLBCL
Where
Ann Arbor, Atlanta, Augusta, Baltimore, Birmingham, Boston, Chicago, Columbus, Dallas, Denver, Durham, Gilbert, Houston, La Jolla, Miami, Milwaukee, Nashville, New Haven, New York, Omaha, Phoenix, Pittsburgh, Portland, Rochester, San Antonio, Seattle, Stanford, St Louis, Westwood
Age
18 years and over
People
315 worldwide
Run by
Miltenyi Biomedicine GmbH
See details and how to joinNCT04792489 · EU 2023-508508-39-01
Phase 1Taking people
Preliminary Safety and Tolerability of CD19x22 CAR T Cells in Adolescent and Adult R/R B-NHL Patients
Where
Aurora
Age
16 years and over
People
68
Run by
University of Colorado, Denver
See details and how to joinNCT05098613
No phaseTaking people
Evaluation of Human Immune Responses Vaccination in Patients With Lymphoma
Where
Atlanta
Age
18 years and over
People
200
Run by
Emory University
See details and how to joinNCT03501576
Phase 1Taking people
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Where
Atlanta, Bethesda, Chicago, Cincinnati, Cleveland, Denver, Duarte, Durham, Houston, Ithaca, Miami, Milwaukee, New Haven, New York, Philadelphia, Salt Lake City, San Francisco, Sarasota
Age
18 years and over
People
572 worldwide
Run by
Nurix Therapeutics, Inc.
See details and how to joinNCT05131022 · EU 2023-510541-25-00
No phaseTaking people
Registry of Older Patients With Cancer
Where
Boone, Chapel Hill, Greenville, Hendersonville, Morehead City, New Bern, Raleigh
Age
65 years and over
People
3,000
Run by
UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT01137825
Phase 2Taking people
Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
Where
Minneapolis
Age
Up to 60 years
People
300
Run by
Masonic Cancer Center, University of Minnesota
See details and how to joinNCT03314974